Historical development of the understanding of coeliac disease

REFERENCES

Abadie V, Sollid LM, Barreiro LB, Jabri B. Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Ann Rev Immunol 2011; 29: 493-525. (English)

Mustalahti K, Catassi C, Reunanen A, Fabiani E, Heier M, McMillan S, et al. The prevalence of celiac disease in Europe: Results of a centralized, international mass screening project. Ann Med 2010; 42: 587-95. (English)

Ludvigsson ЈF, Card TR, Kaukinen K, Bai J, Zingone F, Sanders DS, et al. Screening for celiac disease in the general population and in high-risk groups. United European Gastroenterol J 2015; 3(2): 106-20. (English)

Radlović N. Celiac disease. Srp Arh Celok Lek 2013; 141(1-2): 122–6. (English)

Troncone R, Auricchio S. Celiac disease. In: Wyllie R, Hyams JS, editors. Pediatric Gastrointestinal and Liver Disease. Philadelphia: Saunders Elsevier Inc; 2006. p. 517-27. (English)

Mäki M. Celiac disease. In: Kleinman RE, Sanderson IR, Goulet O, Sherman PM, Mieli-Vergani G, Shneider BL, editors. Walker’s Pediatric Gastrointestinal Disease. Hamilton: BC Decker Inc; 2008. p. 319-27. (English)

Working Group of European Society of Paediatric Gastroenterology and Nutrition. Revised criteria for diagnosis of coeliac disease. Report. Arch Dis Child 1990; 65: 909-11. (English)

Marsh M. Mucosal pathology in gluten sensitivity. In: Marsh M, editor. Coeliac disease. Oxford: Blackwell Sci Publ; 1992. p. 136-91. (English)

Arranz E, Bode J, Kingstone K, Ferguson A. Intestinal antibody pattern of coeliac disease: association with γ/δ T cell receptor expression by intra-epitelial lymphocytes and other indices of potential coeliac disease. Gut 1994; 35: 476-82. (English)

Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med 2002; 346(3): 180-8. (English)

Catassi C, Fabiani E, Iacono G, D'Agate C, Francavilla R, Biagi F, et al. A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. American Journal of Clinical Nutrition. 2007; 85(1): 160–6. (English)

Tjon May-Ling J, Van Bergen J, Koning F. Celiac disease: how complicated can it get? Immunogenetics. 2010; 62: 641-51. (English)

Freeman HJ. The Neolithic Revolution and Subsequent Emergence of the Celiac Affection. International Journal of Celiac Disease. 2013; 1(1): 19-22. (English)

Adams F, translator. „On The Cœliac Affection“. The extant works of Aretaeus, The Cappadocian. London: Sydenham Society. 1856, 350-1. Dostupno na URL: https://books.google.rs/books?id=v4gIAAAAIAAJ&pg=PA350&redir_esc=y#v=onepage&q&f=false)

Gee, S. J., St. Bartholomew's Hospital Reports, 1888, 24, 17. Dostupno na URL: https://web.archive.org/web/20070926231536/http://web2.bium.univ-paris5.fr/livanc/?cote=epo0466&p=1&do=page

Abel EK. The Rise and Fall of Celiac Disease in the United States. J Hist Med Allied Sci 2010; 65(1): 81-105. (English)

Herter CA. On intestinal infantilism from chronic intestinal infection. New York: Macmillan; 1908. (English)

Haas SV, Haas MP. The treatment of celiac disease with the specific carbohydrate diet; report on 191 additional cases. Am J Gastroenterol 1955; 23(4): 344-60. (English)

Brown A. Some Etiological Factors in the Coeliac Syndrome. Arch Dis Child 1949; 24(118): 99–106. (English)

Parsons LG. Coeliac disease. Am J Dis Child 1932; 43: 1293-346. (English)

Dicke WK. Coeliac disease: Investigation of the harmfull effects of certan types of cereal on patients with coeliac disease (Coeliakie: een onderzoek naar de nadelige invloed van sommige graansoorten op de lijder aan coeliakie) [MD Thesis]. Netherlands: University of Utrecht; 1950 (Dutch).

Anderson C, French J, Sammons H, Frazer A, Gerrard J, Smellie J. Coeliac disease; gastrointestinal studies and the effect of dietary wheat flour. Lancet 1952; 1(17):836-42. (English)

Shiner, M. Jejunal-biopsy tube. Lancet 1956; 1:85. (English)

Royer M, Croxatto O, Biempica L, Balcazar Morrison AJ. Duodenal biopsy by aspiration under radioscopic control. Prensa Med Argent 1955; 42(33): 2515-9. (Spanish)

Shiner M. Small intestinal biopsies by the oral route; histopathologic changes in the malabsorption syndrome. J Mt Sinai Hosp N Y 1957; 24(3): 273-85. (English)

Weijers HA, Van de Kamer JH, Dicke WK. Coeliac disease. II. The presence in wheat of a factor having a deleterious effect in cases of coeliac disease. Advanced Pediatric. 1957; 9: 277-318. (English)

Crosby WH, Kugler HW. Intraluminal biopsy of the small intestine: the intestinal biopsy capsule. Dig Dis Sci 1957; 2: 236-39. (English)

Koprowski R. Overview of technical solutions and assessment of clinical usefulness of capsule endoscopy. Biomed Eng Online 2015; 14: 111. (English)

Ciaccio EJ, Lewis SK, Bhagat G, Green PH. Coeliac disease and the videocapsule: what have we learned till now. Ann Transl Med 2017; 5(9): 197. (English)

Paulley JW. Observation on the aetiology of idiopathic steatorrhoea; jejunal and lymph-node biopsies. Br Med J 1954; 2(4900): 1318-21. (English)

Sakula J, Shiner M. Coeliac disease with atrophy of the small-intestine mucosa. Lancet. 1957; 273(7001): 876-7. (English)

Macdonald WC, Dobbins WO, Rubin CE. Studies of the familial nature of celiac sprue using biopsy of the small intestine. N Engl J Med 1965; 272(9): 448-56. (English)

Meuwisse GW. Diagnostic criteria in coeliac disease. Acta Paediatr Scand 1970; 59: 461-3. (English)

Ferguson A, MacDonald TT, McClure JP, Holden RJ. Cell-mediated immunity to gliadin within the small-intestinal mucosa in coeliac disease. Lancet 1975; 1: 895-7. (English)

Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterology 1992; 102: 330-54. (English)

Lundin KE, Scott H, Hansen T, Paulsen G, Hals-tensen TS, Fausa O et al. Gliadin-specific, HLA-DQ(a1*0501,b1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 1993; 178: 187-96. (English)

Lundin KA, Scott H, Fausa O, Thorsby E, Sollid LM. T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8. Hum Immunol 1994; 41: 285-91. (English)

Mäki M, Hällström O, Marttinen A. Reaction of human noncollagenous polypeptides with coeliac disease autoantibodies. Lancet 1991; 338: 724-5. (English)

Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO et al. Identifi cation of tissue transgluta-Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997; 3: 797-801. (English)

van de Wal Y, Kooy Y, van Veelen P, Pena S, Mearin L, Papadopoulos G et al. Selective deamidation by tissue transglutaminase strongly en-hances gliadin-specific T cell reactivity. J Immunol 1998; 161: 1585-8. (English)

Molberg O, Mcadam SN, Körner R, Quarsten H, Kristiansen C, Madsen L et al. Tissue transglutaminase selectively modifies gliadin peptides that are recog nized by gut-derived T cells in celiac disease. Nat Med 1998; 4: 713-7. (English)

Osman AA, Gunnel T, Dietl A, Uhlig HH, Amin M, Fleckenstein B et al. B-cell epitopes of gliadin. Clin Exp Immunol 2000; 121: 248-54. (English)

Aleanzi M, Demonte AM, Esper C, Garcilazo S, Waggener M. Celiac disease: antibody recognition against native and selectively deamidated gliadin peptides. Clin Chem 2001; 47: 2023-8. (English)

Arentz-Hansen H, Körner R, Molberg O, Quarsten H, Vader W, Kooy YM et al. The intestinal T cell re-The intestinal T cell re-sponse to alpha-gliadin in adult celiac disease is fo-cused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med 2000; 191: 603-12. (English)

Kuja-Halkola R, Lebwohl B, Halfvarson J, Wijmenga C, Magnusson PK, Ludvigsson JF. Heritability of non-HLA genetics in coeliac disease: a population-based study in 107 000 twins. Gut 2016; 65: 1793-8. (English)

Dubois PC, Trynka G, Franke L, Hunt KA, Romanos J, Curtotti A, et al. Multiple common variants for celiac disease influencing immune gene expression. Nat Genet 2010; 42: 295-302. (English)

Volta U, Villanacci V. Celiac disease: diagnostic criteria in progress. Cell Mol Immunol 2011; 8(2): 96-102. (English)

Stene LC, Honeyman MC, Hoffenberg EJ, Haas JE, Sokol RJ, Emery L, et al. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol 2006; 101(10): 2333-40. (English)

Silano M, Agostoni C, Guandalini S. Effect of the timing of gluten introduction on the development of celiac disease. World J Gastroenterol 2010; 16(16): 1939-42. (English)

Sanz Y, De Pama G, Laparra M. Unraveling the ties between celiac disease and intestinal microbiota. Int Rev Immunol. 2011; 30(4): 207-18. (English)

du Pré MF, Sollid LM. T-cell and B-cell immunity in celiac disease. Best Pract Res Clin Gastroenterol 2015; 29: 413-23. (English)

Kim SM, Mayassi T, Jabri B. Innate immunity: actuating the gears of celiac disease pathogenesis. Best Pract Res Clin Gastroenterol 2015; 29: 425-35. (English)

Mazzarella G. Effector and suppressor T cells in celiac disease. World J Gastroenterol 2015; 21: 7349-56. (English)

Björck S, Lindehammer SR, Fex M, Agardh D. Serum cytokine pattern in young children with screening detected coeliac disease. Clin Exp Immunol 2015; 179(2): 230-5. (English)

Troncone R, Jabri B. Coeliac disease and gluten sensitivity. J Intern Med 2011; 269: 582-590. (English)

Matthias T, Neidhöfer S, Pfeiffer S, Prager K, Reuter S, Gershwin ME. Novel trends in celiac disease. Cell Mol Immunol 2011; 8: 121-125. (English)

Husby S, Koletzko S, Korponay-Szabo IR, Mearin ML, Phillips A, Shamir R, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012; 54:136-60. (English)

Gianfrani C, Siciliano RA, Facchiano AM, Camarca A, Mazzeo MF, Costantini S, et al. Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease. Gastroenterology 2007; 133: 780-9. (English)

Van den Broeck HC, Van Herpen TW, Schuit C, Salentijn EM, Dekking L, Bosch D, et al. Removing celiac disease-related gluten proteins from bread wheat while retaining technological properties: a study with Chinese Spring deletion lines. BMC Plant Biol 2009; 9:41-53. (English)

De Angelis M, Rizzello CG, Fasano A, Clemente MG, De Simone C, Silano M, et al. VSL#3 probiotic preparation has the capacity to hydrolyze gliadin polypeptides responsible for celiac sprue. Biochim Biophys Acta 2006; 1762: 80-93. (English)

Gass J, Bethune MT, Siegel M, Spencer A, Khosla C. Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue. Gastroenterology 2007; 133: 472-80. (English)

Tye-Din JA, Anderson RP, Ffrench RA, Brown GJ, Hodsman P, Siegel M, et al. The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo. Clin Immunol 2010; 134: 289-95. (English)

Fuhrmann G, Leroux JC. In vivo fluorescence imaging of exogenous enzyme activity in the gastrointestinal tract. Proc Natl Acad Sci US A 2011; 108: 9032-7. (English)

Dhal PK, Polomoscanik SC, Avila LZ, Holmes-Farley SR, Miller RJ. Functional polymers as therapeutic agents: concept to market place. Adv Drug Deliv Rev 2009; 61: 1121-30. (English)

Leffler DA, Kelly CP, Green PHR, Fedorak RN, DiMariano A, Perrow W, Rasmussen H, et al. Larazotide Acetate for Persistent Symptoms of Celiac Disease Despite a Gluten-Free Diet: A Randomized Controlled Trial. Gastroenterology. 2015; 148(7): 1311-9. (English)

Paterson BM, Lammers KM, Arrieta MC, Fasano A, Meddings JB. The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study. Aliment Pharmacol Ther 2007; 26: 757-66. (English)

Huibregtse IL, Marietta EV, Rashtak S, Koning F, Rottiers P, David CS, et al. Induction of antigenspecific tolerance by oral administration of Lactococcus lactis delivered immunodominant DQ8-restricted gliadin peptide in sensitized nonobese diabetic Ab° Dq8 transgenic mice. J Immunol 2009; 183: 2390-6. (English)

Schuppan D, Junker Y, Barisani D. Celiac disease: from pathogenesis to novel therapies. Gastroenterology 2009; 137: 1912-33. (English)

Pardin C, Roy I, Lubell WD, Keillor JW. Reversible and competitive cinnamoyl triazole inhibitors of tissue transglutaminase. Chem Biol Drug Des 2008; 72: 189-96. (English)

Ozaki S, Ebisui E, Hamada K, Goto J, Suzuki AZ, Terauchi A, et al. Potent transglutaminase inhibitors, aryl beta-aminoethyl ketones. Bioorg Med Chem Lett 2010; 20: 1141-4. (English)

Siegel M, Xia J, Khosla C. Structure-based design of alpha-amido aldehyde containing gluten peptide analogues as modulators of HLA-DQ2 and transglutaminase 2. Bioorg Med Chem 2007; 15: 6253-61. (English)

Sollid LM, Khosla C. Novel therapies for coeliac disease. J Intern Med 2011; 269: 604-13. (English)